Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
CA Stock MarketDetailed Quotes
NuGen Medical Devices Inc (NGMD)
- 0.030
- 0.0000.00%
15min DelayMarket Closed Apr 23 16:00 ET
6.81MMarket Cap-10.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.030Prev Close0.00Turnover0.09052wk High0.00%Turnover Ratio227.04MShares0.01552wk Low-0.003EPS TTM6.65MFloat Cap0.530Historical HighLossP/E (Static)221.60MShs Float0.015Historical Low-0.02EPS LYR0.00%Range %--Dividend TTM-0.79P/B1Lot Size--Div Yield TTM
NuGen Medical Devices Inc (NGMD) Cash Flow
Quarterly+Annual
YOY
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -17.97%-1.05M | -230.91%-709.98K | -0.75%-819.51K | 29.79%-4.71M | -123.87%-2.79M | 1.79%-893.56K | 91.45%-214.56K | 60.28%-813.44K | -215.07%-6.71M | -704.17%-1.25M |
| Net income from continuing operations | 36.91%-1.87M | -144.75%-2.33M | 185.72%1.57M | 44.18%-5.23M | 119.82%510.23K | -29.62%-2.96M | 60.29%-950.87K | 13.48%-1.83M | -67.84%-9.36M | -47.43%-2.57M |
| Operating gains losses | -119.61%-88.58K | 228.48%625.99K | -8,574.73%-3.04M | -3,273.49%-2.05M | ---2.05M | --451.72K | -2,764.96%-487.24K | -65.64%35.83K | --64.53K | ---- |
| Depreciation and amortization | 9.10%169.56K | 2.43%163.78K | -8.51%157.61K | -6.53%645.73K | 3.57%158.14K | -12.93%155.42K | -10.52%159.89K | -4.80%172.28K | 5.89%690.84K | -19.25%152.69K |
| Remuneration paid in stock | --0 | --0 | --0 | -93.06%94.69K | --0 | -6.43%44.18K | --0 | -91.12%50.51K | 215.92%1.36M | 128.39%443.5K |
| Deferred tax | -142.31%-4.53K | --4.14K | --3.89K | -80.06%6.74K | -115.60%-3.97K | 1,147.03%10.71K | --0 | --0 | 963.10%33.8K | 1,904.09%25.47K |
| Other non cashItems | 119.84%800.75K | -3.72%737.06K | 118.73%671.21K | 75.13%2.15M | 233.68%715.73K | 1.40%364.24K | 136.20%765.56K | -7.36%306.87K | -30.13%1.23M | -20.15%214.49K |
| Change In working capital | -106.59%-69.15K | -69.66%90.43K | -139.70%-177.62K | 53.19%-339.78K | -600.86%-2.13M | 18.95%1.05M | 132.70%298.1K | 139.85%447.42K | -220.20%-725.79K | -54.61%426.26K |
| -Change in receivables | 144.34%69.82K | -52.53%24.73K | -42.66%141.38K | 208.35%104.92K | -232.15%-36.28K | -11.37%-157.48K | -47.54%52.1K | 400.01%246.58K | -255.14%-96.83K | 173.79%27.46K |
| -Change in inventory | -113.60%-26.74K | 129.53%102.13K | -541.25%-94.75K | 15.90%-111.44K | 113.04%16.39K | 4,040.67%196.6K | -4,300.24%-345.9K | 260.12%21.47K | -107.46%-132.51K | -104.61%-125.63K |
| -Change in prepaid assets | 171.80%11.04K | -432.86%-78.24K | -96.50%4.22K | 170.83%95.79K | -107.60%-32.69K | -102.02%-15.38K | 104.21%23.51K | 115.64%120.35K | -212.60%-135.23K | 74.69%430.41K |
| -Change in payables and accrued expense | -116.03%-176.74K | -73.13%39.27K | -405.32%-226.53K | -21.89%-459.19K | -997.21%-1.78M | 361.61%1.1M | 127.23%146.13K | 126.73%74.19K | -161.58%-376.73K | -73.67%198.64K |
| -Change in other working capital | 169.69%53.46K | -99.40%2.54K | 87.27%-1.93K | 94.28%30.15K | -186.99%-300.22K | -381.19%-76.71K | 357.91%422.26K | -2,486.79%-15.18K | -57.81%15.52K | ---104.61K |
| Tax refund paid | 142.31%4.53K | ---4.14K | ---3.89K | --0 | 1,071,100.00%10.71K | ---10.71K | --0 | --0 | -161.81%-8.32K | 100.08%1 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -17.97%-1.05M | -230.91%-709.98K | -0.75%-819.51K | 29.79%-4.71M | -123.87%-2.79M | 1.81%-893.56K | 91.45%-214.56K | 60.28%-813.44K | -215.07%-6.71M | -704.17%-1.25M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -20,300.53%-76.5K | -14,019.73%-52.95K | 0 | 77.63%-11.94K | -218.49%-10.82K | 99.25%-375 | -375 | -375 | -5,202.58%-53.4K | -3.4K |
| Net PPE purchase and sale | ---75.4K | ---- | ---- | -243.32%-10.38K | ---10.38K | --0 | ---- | ---- | -200.10%-3.02K | ---- |
| Net other investing changes | ---- | ---- | ---- | 96.89%-1.57K | -18.40%-444 | ---375 | ---375 | ---375 | ---50.38K | ---375 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -20,300.53%-76.5K | -14,019.73%-52.95K | --0 | 77.63%-11.94K | -218.49%-10.82K | 99.25%-375 | ---375 | ---375 | -5,202.58%-53.4K | ---3.4K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | -91.87%60.5K | 57.84%11.21M | 710.52%405K | 662.80%10.07M | -100.21%-7.03K | -68.53%744.23K | 1,282.02%7.1M | -46.58%49.97K |
| Net issuance payments of debt | --0 | --0 | --0 | 74.69%9.97M | --0 | 32,866.47%10M | 99.14%-7.03K | 34.90%-20.77K | 6,905.04%5.71M | 21,048.57%6.59M |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | --0 | --0 | --0 | 878.17%6.58M | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | -92.09%60.5K | -11.28%1.24M | 912.50%405K | -95.19%65K | --0 | --765K | --1.39M | --40K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | -91.87%60.5K | 57.84%11.21M | 710.52%405K | 662.80%10.07M | -100.21%-7.03K | -68.53%744.23K | 1,282.02%7.1M | -46.58%49.97K |
| Net cash flow | ||||||||||
| Beginning cash position | 3,036.72%5.42M | 1,466.80%6.19M | 1,395.51%6.95M | 253.33%464.46K | 461.15%9.34M | -86.31%172.92K | -12.85%394.88K | 253.33%464.46K | -92.49%131.45K | 762.74%1.67M |
| Current changes in cash | -112.33%-1.13M | -243.73%-762.93K | -990.89%-759.01K | 1,846.37%6.48M | -99.72%-2.4M | 2,451.60%9.17M | -125.88%-221.96K | -121.98%-69.58K | 120.58%333.01K | -1,850.59%-1.2M |
| Effect of exchange rate changes | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| End cash Position | -54.05%4.29M | 3,036.72%5.42M | 1,466.80%6.19M | 1,395.51%6.95M | 1,395.51%6.95M | 461.15%9.34M | -86.31%172.92K | -12.85%394.88K | 253.33%464.46K | 253.33%464.46K |
| Free cash from | -26.41%-1.13M | -255.58%-762.93K | -0.75%-819.51K | 29.67%-4.72M | -124.16%-2.8M | 1.81%-893.56K | 91.45%-214.56K | 60.28%-813.44K | -215.06%-6.72M | -706.12%-1.25M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm